Clinical Trial Update: Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-responders [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated adding interferon-gamma to interferon-alpha and ribavirin for hepatitis C in patients who did not respond to prio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Interferon-alpha (interferon alpha)
• Interferon-gamma (interferon gamma)
• Ribavirin (ribavirin)

Snippet

Sponsor: Aga Khan University | Conditions: Hepatitis C, Genotype 3 | Phase 2, Phase 3 | Status: COMPLETED